文献速递甲状腺疾病

多中心基准研究揭示美国甲状腺检测存在显著差异

Multi-Center Benchmark Study Reveals Significant Variation in Thyroid Testing in United States.
PubMed 文献 · Thyroid · 2017-07-05

该研究通过调查收集美国82个站点甲状腺检测年检测量及实验室利用管理活动数据,发现甲状腺检查率(TSH/CBC)门诊为0.26、住院为0.03,检测选择存在显著实践差异,提示需要更好的检测选择指导。

要点

  • 甲状腺检查率(TSH/CBC)门诊0.26高于住院0.03。
  • 每100个TSH医嘱中位数对应14个FT4、3个TT4、4个FT3、2个TT3、0.1个rT3和0.1个T3U。
  • 所有检测项目选择均存在显著实践差异,rT3/TSH和T3U/TSH比值变异性最高。

核心结论

  • 甲状腺检测存在相当大的实践差异,提示需要更好的检测选择指导;基于样本,一些机构可显著改善甲状腺检测质量并降低检测成本。

研究设计与样本

  • 调查收集美国站点甲状腺刺激激素(TSH)、游离甲状腺素(FT4)、总甲状腺素(TT4)、游离三碘甲状腺原氨酸(FT3)、总三碘甲状腺原氨酸(TT3)、三碘甲状腺原氨酸摄取(T3U)、反三碘甲状腺原氨酸(rT3)和全血细胞计数(CBC)的年检测量及实验室利用管理活动数据,共获得82个站点数据。

主要发现

  • 甲状腺检查率(TSH/CBC)门诊为0.26,住院为0.03。
  • 基于中位数,每100个TSH医嘱对应14个FT4、3个TT4、4个FT3、2个TT3、0.1个rT3和0.1个T3U。
  • T4医嘱中约90%为FT4而非TT4;T3医嘱在FT3与TT3之间几乎均匀分布。
  • 所有检测项目选择均存在显著实践差异,rT3/TSH和T3U/TSH比值变异性最高。
  • 多数机构报告至少有一些实验室利用管理活动,利用管理举措与甲状腺检测医嘱质量之间关系较弱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies show that a significant portion of laboratory testing is unnecessary. Thyroid tests are some of the most commonly ordered laboratory tests, yet little is known about practice patterns for laboratory testing for thyroid disease. The objective of this study was to collect data on practice patterns for thyroid testing in the United States. METHODS: A survey was conducted to collect data on annual test volumes for thyroid stimulating hormone (TSH), free thyroxine (FT4), total thyroxine (TT4), free triiodothyronine (FT3), total triiodothyronine (TT3), triiodothyronine uptake (T3U), reverse triiodothyronine (rT3), and complete blood counts (CBC). Sites were also asked to provide data on laboratory utilization management activities. Thyroid workup rates were compared using the TSH/CBC ratio. Thyroid test selection patterns were compared using the ratio of order volumes for thyroid tests relative to TSH. RESULTS: We obtained data from 82 sites. The thyroid workup rate (TSH/CBC) was higher for outpatients (0.26) than for inpatients (0.03). Based on median values, sites ordered 14 FT4, 3 TT4, 4 FT3, 2 TT3, 0.1 rT3, and 0.1 T3U for every 100 TSH orders. The majority (approximately 90%) of orders for T4 were for FT4 rather than TT4. Orders for T3 were almost evenly split between FT3 and TT3. There was significant practice variation in test selection for all tests. The highest variability was for the rT3/TSH and T3U/TSH ratios. Most organizations reported at least some laboratory utilization management activities. There was a weak relationship between utilization management initiatives and the quality of orders for thyroid tests. CONCLUSIONS: There is considerable practice variation in thyroid testing which suggests a need for better guidance in test selection. Based on our sample, some organizations could significantly improve the quality of thyroid testing and reduce testing costs.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Lin DC, Straseski JA, Schmidt RL, et al. Multi-Center Benchmark Study Reveals Significant Variation in Thyroid Testing in United States. Thyroid. 2017. PMID: 28679353. doi:10.1089/thy.2017.0190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。